Xintian Pharmaceutical: Announcement on the cumulative amount of Xintian debt-for-share conversion reached 10% of the total amount of shares issued by the company before the conversion
Xintian Pharmaceutical: An important indicative announcement on the implementation of Xintian\'s redemption of bonds and the imminent cessation of stock conversion
Xintian Pharmaceutical: Important reminder on the implementation of Xintian\'s redemption of bonds and the upcoming cessation of trading
Xintian Pharmaceutical: Important reminder on the implementation of Xintian\'s redemption of bonds and the upcoming cessation of trading
Xintian Pharmaceutical: Important reminder on the implementation of Xintian\'s redemption of bonds and the upcoming cessation of trading
Xintian Pharmaceutical: 9th indicative announcement on early redemption of Xintian Convertible Bonds
Xintian Pharmaceutical: Eighth indicative announcement on early redemption of Xintian Convertible Bonds
Xintian Pharmaceutical: Seventh indicative announcement on early redemption of Xintian Convertible Bonds
Xintian Pharmaceutical: Sixth indicative announcement on early redemption of Xintian Convertible Bonds
Xintian Pharmaceutical: Fifth indicative announcement on early redemption of Xintian Convertible Bonds
Xintian Pharmaceutical: Fourth indicative announcement on early redemption of Xintian Convertible Bonds
Xintian Pharmaceutical: Third indicative announcement on early redemption of Xintian Convertible Bonds
Xintian Pharmaceutical: Second indicative announcement on early redemption of Xintian Convertible Bonds
Xintian Pharmaceutical: First indicative announcement on early redemption of Xintian Convertible Bonds
Xintian Pharmaceutical: Beijing Deheng Law Firm\'s Legal Opinion on the Company\'s Early Redemption of Convertible Corporate Bonds
Xintian Pharmaceutical: Announcement on Early Redemption of Xintian Convertible Bonds
Xintian Pharmaceutical: An indicative announcement on whether Xintian Convertible bonds may meet the redemption conditions
Xintian Pharmaceutical: An indicative announcement on the adjustment of Xintian debt-for-equity conversion price
Xintian Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the third quarter of 2024
Xintian Pharmaceutical: Announcement on Cancelling Capital Reduction of Some Repurchased Shares and Notifying Creditors